BiotechTube
Home/Lodestone Biomedical/Brendan Flynn, Ph.D.
BF

Brendan Flynn, Ph.D.

Chief Executive Officer

Lodestone Biomedical

Therapeutic Areas

Oncology

Lodestone Biomedical Pipeline

DrugIndicationPhase
IRIS Biosensor PlatformPreclinical Cancer Research & Drug DevelopmentResearch-Use-Only

Leadership Team at Lodestone Biomedical

SD
Sol Diamond, Ph.D.
Chief Technology Officer & Co-Founder
View full Lodestone Biomedical profile